238 related articles for article (PubMed ID: 36512300)
1. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review.
Ong R; Cornish J; Wen J
Biometals; 2023 Jun; 36(3):709-727. PubMed ID: 36512300
[TBL] [Abstract][Full Text] [Related]
2. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer.
Muj C; Mukhopadhyay S; Jana P; Kondapi AK
Cancer Chemother Pharmacol; 2023 May; 91(5):375-387. PubMed ID: 36977771
[TBL] [Abstract][Full Text] [Related]
3. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.
Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP
Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals.
Nocerino N; Fulgione A; Iannaccone M; Tomasetta L; Ianniello F; Martora F; Lelli M; Roveri N; Capuano F; Capparelli R
Int J Nanomedicine; 2014; 9():1175-84. PubMed ID: 24623976
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications.
Sabra S; Agwa MM
Int J Biol Macromol; 2020 Dec; 164():1046-1060. PubMed ID: 32707283
[TBL] [Abstract][Full Text] [Related]
7. Lipid-Based Nanostructures for the Delivery of Natural Antimicrobials.
Pinilla CMB; Lopes NA; Brandelli A
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208209
[TBL] [Abstract][Full Text] [Related]
8. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin.
Tammam SN; Azzazy HME; Lamprecht A
Eur J Pharm Biopharm; 2018 Aug; 129():74-79. PubMed ID: 29802982
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection.
Fulgione A; Nocerino N; Iannaccone M; Roperto S; Capuano F; Roveri N; Lelli M; Crasto A; Calogero A; Pilloni AP; Capparelli R
PLoS One; 2016; 11(7):e0158646. PubMed ID: 27384186
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and characterization of zein/lactoferrin composite nanoparticles for encapsulating 7,8-dihydroxyflavone: Enhancement of stability, water solubility and bioaccessibility.
Chen Y; Zhao Z; Xia G; Xue F; Chen C; Zhang Y
Int J Biol Macromol; 2020 Mar; 146():179-192. PubMed ID: 31899246
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine.
Agwa MM; Sabra S
Int J Biol Macromol; 2021 Jan; 167():1527-1543. PubMed ID: 33212102
[TBL] [Abstract][Full Text] [Related]
12. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
13. Potential biological fate of emulsion-based delivery systems: lipid particles nanolaminated with lactoferrin and β-lactoglobulin coatings.
Tokle T; Mao Y; McClements DJ
Pharm Res; 2013 Dec; 30(12):3200-13. PubMed ID: 23462931
[TBL] [Abstract][Full Text] [Related]
14. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.
Andima M; Boese A; Paul P; Koch M; Loretz B; Lehr CM
ACS Infect Dis; 2024 May; 10(5):1696-1710. PubMed ID: 38577780
[TBL] [Abstract][Full Text] [Related]
15. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY
Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.
Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA
Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
18. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
19. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
Wu Y; Zhang B; Kebebe D; Guo L; Guo H; Li N; Pi J; Qi D; Guo P; Liu Z
Pharm Dev Technol; 2019 Oct; 24(8):982-991. PubMed ID: 31107131
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand.
Elzoghby AO; Abdelmoneem MA; Hassanin IA; Abd Elwakil MM; Elnaggar MA; Mokhtar S; Fang JY; Elkhodairy KA
Biomaterials; 2020 Dec; 263():120355. PubMed ID: 32932142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
